Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma

Figure 4

Immunohistochemical expression of p16 in non-neoplastic liver tissue and hepatocellular carcinoma. A moderately differentiated HCC is completely immunonegative for p16 (left). The non-neoplastic liver tissue shows immunostaining for p16 in scattered ductular reactions and mild cytoplasmic immunostaining in few periportal and periseptal hepatocytes (right). Anti-p16-antibody. Hematoxylin-counterstain.

Back to article page